Podcast
The Beat
Hosted by HLTH · EN
The Beat, powered by HLTH, is an executive interview series with healthcare leaders, founders ,and investors sharing insights on growth, innovation and business building.
10episodes
Episodes
Newest firstAll episodes
S1 Ep14: Why Startups Shape Samsung's Future with Jonathan Machado
Mar 4, 202400:13:03Tap to summarizeAbout Jonathan Machado:Jonathan Machado is the Managing Director of Samsung Next, which is Samsung Electronics' venture capital arm. He is in charge of making investments in health tech. He has helped Samsung Next participate in many businesses, such as BigHealth, Healthy.io, Huma Therapeutics, Lark, Elvie, and DayTwo.Jonathan worked as an investor and partner at Jerusalem Venture Partners for five years before joining Samsung Next in 2018. There, he focused on early-stage Israeli startups. Besides that, he has an MBA from The Hebrew University of Jerusalem. Jonathan was born and raised in Jerusalem. He and his family just moved to the New York metropolitan area.Things You’ll Learn:Samsung Next adopts a unique VC model with "no proof," fostering a collaborative environment with entrepreneurs.Success stories like LoopPay and SmartThings demonstrate Samsung NEXT's strategic investments that align with long-term corporate goals.Samsung's healthcare vision involves enabling users to own their health records, creating a paradigm shift in personal healthcare management.Soon, Samsung Health’s tens of millions of users will be able to own their records and begin a journey of owning their health care through these records.Samsung Next measures success through regular VC metrics, emphasizing ROI and influencing strategic decisions within the company.Resources:Connect with and follow Jonathan Machado on LinkedIn.Follow Samsung Next on LinkedIn and visit their website.
Transcribe →S1 Ep13: A Holistic Solution to Sustained Mental Well-being with Mark Frank
Feb 26, 202400:10:24Tap to summarizeAbout Mark Frank:Mark Frank is the CEO and Co-founder of SonderMind, leading a rapidly expanding and compassionate team dedicated to reshaping behavioral health. His mission is to enhance access, broaden utilization, and elevate clinical outcomes in this field. Mark believes in transparent, empathetic, and courageous leadership, aspiring to build an organization that leaves a positive and transformative impact on behavioral health and the broader healthcare ecosystem. Before founding SonderMind in 2015, Mark played a pivotal role in establishing three other successful ventures, including Next Oncology, TermScout, and SafeImageMD. His entrepreneurial journey follows a background in healthcare investment banking at Morgan Stanley, Lehman Brothers, and CDI Global, coupled with military service as an officer in the US Army.With degrees in Computer Science, Computer Information Systems, Engineering Management, and an MBA in Finance and Operations, Mark's commitment stems from personal experiences, witnessing the challenges faced by friends and colleagues in accessing mental health care after military deployments.Things You’ll Learn:AI helps personalize care pathways for patients and assists providers in delivering the highest quality care efficiently.The world is in a mental health crisis. Competition and innovation are crucial to solving this massive problem.Mental health care is not discretionary. It has an immense impact on physical health and overall well-being.Engage patients through various channels, including employers, health systems, payers, and consumers.SonderMind serves as a mental health home, providing comprehensive digital tools for sustained well-being.Resources:Connect with and follow Mark Frank on LinkedIn.Follow SonderMind on LinkedIn and visit their website.
Transcribe →S1 Ep12: The Future of Home Healthcare with Vijay Kedar
Feb 19, 202400:15:56Tap to summarizeAbout Vijay Kedar:Vijay Kedar, co-founder and CEO of Tomorrow Health, was raised in a family of physicians, often joking that he was “pre-med coming out of the womb.” However, it wasn’t until he took on managing his mother's care through stage III colorectal cancer and acute respiratory distress syndrome that the idea for Tomorrow Health was born. In this episode, Kedar speaks with host Steve Krupa about using technology to coordinate high-quality home-based care for patients and families who find securing such care increasingly difficult to navigate.Kedar also discusses how home-based care improves health outcomes, alleviates the administrative and healthcare burden for providers, and is often the most economical option for patients requiring long-term treatment. He says, “Treating a patient with the same conditions at home can be one-tenth the cost of doing so in a hospital-based setting and one-third the cost of doing so in a post-acute setting like a skilled nursing facility.” Kedar goes on to outline how Tomorrow Health’s launch during the pandemic essentially changed how home-based care was ordered, delivered, and purchased to meet an ever-growing demand.Things You’ll Learn:Tomorrow Health emphasizes the use of technology and strategic partnerships to enhance the efficiency of coordinating and delivering home-based healthcare. Tomorrow Health’s commitment aims to provide patients and families across the nation with more dependable and higher-quality care.Vijay highlighted the significance of tackling distinct challenges faced by different stakeholders in the home-based care ecosystem. Through aligning incentives and consistently offering value propositions, Tomorrow Health is expediting the acquisition, engagement, and retention of stakeholders. This strategic approach is paving the way for widespread market adoption.Tomorrow Health is utilizing the capabilities of artificial intelligence to automate operational processes, diminish manual workload, and expedite the delivery of home-based care to patients. Resources:Connect with and follow Vijay Kedar on LinkedIn.Follow Tomorrow Health on LinkedIn.Visit the Tomorrow Health website here.
Transcribe →S1 Ep11: The Future of Virtual Care with Kelly Bliss
Feb 12, 202400:10:07Tap to summarizeAbout Kelly Bliss:Kelly Bliss is president of U.S. Group Health. She oversees sales, client management, and client and commercial operations for the business.Ms. Bliss has strong expertise in creating cohesive client-focused organizations. Most recently, she held the position of chief client officer at Teladoc Health. Under her leadership, client services achieved record growth and retention through a focus on delivering value and a best-in-class experience to our clients. Ms. Bliss also built and managed high-functioning, global teams at companies such as Best Doctors and InterSystems. At Best Doctors, she served as chief of staff, leading the organization's key strategic growth initiatives until the eventual acquisition by Teladoc Health in 2017.Ms. Bliss was recognized as one of the Top 25 Women Leaders in Healthcare Software of 2020 by The Healthcare Technology Report and serves as executive sponsor for the Teladoc Health Women's Network. She holds a bachelor's degree in industrial psychology from Nichols College.Things You’ll Learn:Teladoc places a priority on well-rounded growth, giving significant attention to both revenue and profitability. This commitment is supported by a robust balance sheet and substantial investments in research and development.The growing significance of hyper-personalized member experiences and the utilization of multiple artificial intelligence models to enhance outcomes for clients and members.Kelly Bliss's professional odyssey as a "code breaker" involves challenging norms and assembling unconventional teams to optimize and create high-performance team dynamics.The surge of virtual care is evident, with Teladoc's research indicating a growing trend among employers investing in comprehensive virtual care providers. Resources:Connect with and follow Kelly Bliss on LinkedIn.Follow Teladoc on LinkedIn and visit their website.
Transcribe →S1 Ep10: Navigating Healthcare with Microsoft with Kathleen Mitford
Feb 5, 202400:12:09Tap to summarizeAbout Kathleen Mitford:Kathleen Mitford spent her career crafting strategies and empowering employees to ensure top-notch customer experiences. As the CVP of Global Industry Marketing at Microsoft, she’s proud to work alongside their partner ecosystem to help customers in all industries create the future with solutions across the Microsoft Cloud designed to solve their industry's unique challenges and unlock opportunities. Microsoft’s mission to empower every person and every organization on the planet to achieve more aligns with her own purpose, and she’s thrilled to be part of a company that values inclusivity, empathy, and a growth mindset. She’s a passionate advocate for advancing diversity and equity and promoting greater inclusion of women in science and technology by encouraging diverse perspectives, embracing our differences, and supporting a sense of belonging for all. In her free time, you’ll find her gardening, running, and adventuring with her husband and two kids.Things You’ll Learn:Microsoft is focused on empowering healthcare organizations with the tools and technologies to unlock the potential of their data and harness the power of AI to drive better operational insights and patient care.Microsoft stands apart through its foundation of trust with customers. By prioritizing customer data ownership, security, and privacy, and offering comprehensive solutions, Microsoft is committed to being a trusted advisor in healthcare transformation.Microsoft emphasizes responsible AI practices and supports customers in developing a strong data strategy, foundation, and responsible AI implementation. The power of data in healthcare is unparalleled. Kathleen Mitford highlights how Microsoft's cloud and AI solutions are driving operational insights and improving patient experiences. Resources:Connect with and follow Kathleen Mitford on LinkedIn.Follow Microsoft on LinkedIn and visit their website.
Transcribe →S1 Ep9: Blackstone’s Big Impact on Cost and Quality with Andreas Mang
Jan 29, 202400:13:18Tap to summarizeAbout Andreas Mang:Andreas Mang serves as the CEO of Equity Healthcare, where he oversees the management of medical benefits spending across Blackstone's portfolio. With two decades of experience in healthcare, Mr. Mang has worked in various capacities in healthcare finance, operations, and strategy.Before joining Blackstone, he was the Vice-President responsible for national provider network operations at CareCentrix, a prominent home health benefit-management company backed by private equity. Earlier, at Blue Cross Blue Shield of Massachusetts, he played a leadership role in identifying and implementing cost-saving measures across the organization and played a key role in designing a new corporate business model. Mr. Mang also worked at Harvard Pilgrim Health Care as the Manager of Strategic Financial Planning and served as a Senior Consultant with Deloitte Consulting’s Strategy and Operations group in Boston.Things You’ll Learn:Healthcare is notably unhealthy in the US.It will take a considerable amount of time for value-based care to be distributed at scale.No problem is too big to solve.Tangible outcomes include lower readmission rates and improved care management for employees going through treatments like chemotherapy.The ease of getting carrier partners on board is attributed to Blackstone's size, scale, and growth trajectory, creating a win-win situation.Resources:Connect with and follow Andreas Mang on LinkedIn.Follow Blackstone on LinkedIn and visit their website.
Transcribe →S1 Ep8: Navigating Recession, Inflation, and Workforce Challenges In Healthcare with Warner Thomas
Jan 22, 202400:13:20Tap to summarizeAbout Warner Thomas:Warner Thomas serves as the president and CEO of Sutter Health, a non-profit health system based in Northern California. Leading a team of over 50,000 employees, 12,000 physicians, and 2,000 advanced practice clinicians, Thomas oversees an integrated delivery system covering hospitals, outpatient care centers, home health, hospice care, labs, pharmacies, and research facilities. Before joining Sutter Health, he spent a decade as the president and CEO of Ochsner Health in Louisiana, where he focused on population health and initiated innovationOchsner, a lab for healthcare advancementsThomas is a member of the American Hospital Association (AHA) Board of Trustees, a fellow of the American College of Healthcare Executives, and has contributed to healthcare policy by advising Congress. Recognized as one of the 100 Most Influential People in Healthcare by Modern Healthcare in 2022 and 2023, he also earned distinctions such as being named to Becker's Healthcare's list of Top Hospital and Health System CEOs to Know in 2023. Beyond his professional achievements, Thomas has received honors like the Distinguished Citizen Award from the Boy Scouts of America and the A.I. Botnick Torch of Liberty Award from the Anti-Defamation League.Things You’ll Learn:You have to be willing to take calculated risks.If you sit back and wait for things to be perfect, it's never going to happen, and you'll miss opportunities.You must be willing to take on a new challenge and move outside your comfort zone.You can't shrink your way to greatness.When you do a great job taking care of patients daily, why wouldn't you want to expand and serve even more people?Resources:Connect with and follow Warner Thomas on LinkedIn.Follow Sutter Health on LinkedIn and visit their website.Check out the Sutter Health app here.
Transcribe →S1 Ep7: The Mystery of Obesity with Dr. Rekha Kumar
Jan 15, 202400:09:10Tap to summarizeAbout Rekha Kumar:Dr. Rekha Kumar is a globally recognized leader in the field of Obesity Medicine, currently holding the position of Chief Medical Officer at Found, a weight care platform. With a past role as the medical director of the American Board of Obesity Medicine, Dr. Kumar has shared her insights on the international stage regarding the medical evaluation and treatment of obesity. Contributing significantly to her field, she has authored various papers and textbook chapters and serves as an Associate Editor for the Obesity Journal. Her expertise extends to diverse topics, including the clinical assessment of patients with obesity and metabolic syndrome, the impact of obesity on reproductive health and fertility, and thyroid disease. Beyond her clinical work, Dr. Kumar has actively participated in global health initiatives, exploring the landscape of metabolic diseases in countries like India, China, and Tanzania. She is a valued member of the board of advisors for the Duke Global Health Institute and holds Board Certifications in Internal Medicine, Endocrinology, Diabetes, & Metabolism, and Obesity Medicine.Things You’ll Learn:Obesity is a heterogeneous disease. What works for one person may not work for another. Found's outcomes boast a 90% success rate, with patients achieving a 10% body weight loss in one year.Research says 40% of adults and 20% of children have obesity. The US obesity treatment market is about $15 billion. The US weight loss market is about 160 billion.There’s a biological component to obesity; it’s not just willpower, diet, and exercise.The root cause of each person’s weight gain can be vastly different.Resources:Connect with and follow Rekha Kumar on LinkedIn.Follow Found on LinkedIn and visit their website.
Transcribe →S1 Ep6: Sanofi's Pattern Recognition in Vaccine Development with Deborah Glasser
Jan 8, 202400:10:51Tap to summarizeAbout Deborah Glasser:Deborah Glasser holds an MBA in Marketing and Finance from the University of Chicago Booth School of Business and a B.A. with honors from Tufts University. Deborah is currently the Head of Vaccines in North America at Sanofi. In this role, she spearheads a team committed to pursuing scientific breakthroughs, focusing on the development and enhancement of immunizations. Sanofi, a global pharmaceutical giant, places a strong emphasis on innovation, and Deborah plays a crucial role in driving the vision forward, expanding access to vaccines, and advancing public health initiatives throughout the U.S. and Canada.Drawing on a rich and varied professional background, Deborah brings more than a decade of experience to her current role. Her journey includes an illustrious 13-year tenure at Biogen, where she held diverse positions across its U.S., European, and global organizations. Notably, she played a key role in the successful launch of Tecfidera, an oral multiple sclerosis product that achieved remarkable success, generating $1.3 billion in U.S. sales within its first four full quarters on the market.Things You’ll Learn:The vaccine industry faces intense competition.RSV stands as the primary reason for infant hospitalizations.Approximately 70 out of every 100,000 individuals end up hospitalized due to the flu.The flu poses a significant and serious risk, with an average of 36,000 deaths annually, potentially reaching 98,000 in severe seasons. These deaths are preventable.It's crucial to recognize the seriousness of the flu and take preventive measures to avoid unnecessary fatalities.Resources:Connect with and follow Deborah Glasser on LinkedIn.Follow Sanofi on LinkedIn and visit their website.
Transcribe →S1 Ep5: Decoding the Future of Healthcare Investment with Josh Flum
Jan 2, 202400:14:26Tap to summarizeAbout Josh Flum:Josh Flum is a Managing Partner at LRVHealth, a company that invests in healthcare ideas. LRVHealth has a skilled team of healthcare experts and partners with others to support new healthcare companies. Before LRVHealth, Flum worked for 20 years at CVS Health in different roles. His latest role there was as Chief Strategy & Business Development Officer, where he handled challenges in the changing healthcare world. Flum led significant changes, like combining CVS Health and Aetna and starting CVS Health Ventures, a fund to support new digital health businesses. He played key roles in senior positions, leading growth in CVS Health’s Retail Pharmacy Division through new and smart ideas. Flum studied at Tufts University and Yale Law School. He began his career working for a U.S. Court of Appeals judge and then at a law firm. Later, he joined the Boston Consulting Group, focusing on the consumer and retail fields.Things You’ll Learn:Investing is both an art and a science, requiring a nuanced blend of strategic thinking and analytical evaluation.Market dynamics resemble a pendulum, with current positioning influenced by past trajectories. Understanding this informs future directions and decision-making.The surge in digital health solutions during the COVID crisis highlights the transformative potential of technology in healthcare.Amid market challenges, it's crucial to reassess and prioritize the fundamental aspects of healthcare for the coming years.There are upcoming changes in how new therapies will be brought to market, commercialized, and integrated into the system for patient access. This includes the exploration of new insurance models to facilitate the payment for these therapies.Resources:Connect with and follow Josh Flum on LinkedIn.Follow LRVHealth on LinkedIn and visit their website.
Transcribe →